Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Cash Taxes Paid
Atara Biotherapeutics Inc
Cash Taxes Paid Peer Comparison
Competitive Cash Taxes Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Cash Taxes Paid
$2k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Taxes Paid
$4.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
166%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Taxes Paid
$4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Taxes Paid
$1.7B
|
CAGR 3-Years
106%
|
CAGR 5-Years
167%
|
CAGR 10-Years
82%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Cash Taxes Paid?
Cash Taxes Paid
2k
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Cash Taxes Paid amounts to 2k USD.
What is Atara Biotherapeutics Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 3Y
-42%
Over the last year, the Cash Taxes Paid growth was -90%. The average annual Cash Taxes Paid growth rates for Atara Biotherapeutics Inc have been -42% over the past three years .